Farhatullah Syed։ Could CAR T Cells Fight Solid Tumors Better by Taking Scheduled Breaks?
Farhatullah Syed/LinkedIn

Farhatullah Syed։ Could CAR T Cells Fight Solid Tumors Better by Taking Scheduled Breaks?

Farhatullah Syed, Group Leader/Senior Scientist at King Faisal Specialist Hospital and Research Centre, shared on LinkedIn:

“Could CAR T cells fight solid tumors better by taking scheduled breaks?

Chen and colleagues’ outstanding study in Cell Reports Medicine introduces MANAGE CAR T cells, combining tumour targeting with externally controlled timing of CAR expression.

An albumin adapter carrying FITC, a fluorescent tag, preferentially accumulates in tumours.

A synthetic Notch receptor detects cell-bound FITC and triggers expression of a separate tumour-targeting CAR.

Spacing adapter doses creates pulses of CAR expression, with intervals of reduced stimulation.

In mice, six-day dosing intervals outperformed shorter and longer schedules tested, preserved stem-like features and reduced exhaustion markers.

Combined with PD-L1 blockade, treatment achieved complete regressions in breast cancer and glioblastoma models.

These findings suggest that externally controlling when CARs are expressed could improve solid-tumour treatment, while introducing a combined cell-and-adapter strategy whose dosing, safety and manufacturing requirements need validation before clinical translation.

These promising preclinical findings provide a strong foundation for further development.

Future studies can clarify human safety, optimal dosing intervals, manufacturing feasibility and how reduced exhaustion contributes to improved tumour control.”

Title: Temporal control of CAR expression by a tumor-targeting albumin adapter and logic gating enhances CAR-T cell therapy for solid tumors

Authors: Jin Chen, Lei Zhao, Cui Shen, Yang Zhou, Yangjing Li, Yuzheng Zhu, Mengqian Gao, Xinyue Wang, Yulun Huang, Yiran Zheng

Read the article

You can also read:

Aleix Prat: A Major Step Toward Bringing CAR-T Therapies to Solid Tumors.

Miguel Bronchud: Exploring CAR-T Therapy for Colorectal and Other Solid Tumors.

Humaid Al-Shamsi։ First-in-Human Results Presented for Novel T-Cell Therapy in Advanced Solid Tumors.